M. M. Albasser, M. Davies, J. E. Futter, and J. P. Aggleton, Magnitude of the object recognition deficit associated with perirhinal cortex damage in rats: Effects of varying the lesion extent and the duration of the sample period, Behav Neurosci, vol.123, pp.115-124, 2009.

S. P. Alexander, A. Christopoulos, A. P. Davenport, E. Kelly, N. V. Marrion et al., , 2017.

. The, . Guide, and . Pharmacology, 18: G protein-coupled receptors, Br J Pharmacol, vol.174, pp.17-129, 2017.

S. Alexander, R. E. Roberts, B. Broughton, C. G. Sobey, C. H. George et al., Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology, Br J Pharmacol, vol.175, pp.407-411, 2018.

H. Ansanay, M. Sebben, J. Bockaert, and A. Dumuis, Characterization of homologous 5-hydroxytryptamine4 receptor desensitization in colliculi neurons, Mol Pharmacol, 1992.

K. Baranger, Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease, Neuropharmacology, vol.126, pp.128-141, 2017.

G. Barthet, Uncoupling and endocytosis of 5-hydroxytryptamine 4 receptors: distinct molecular events with different GRK2 requirements, J Biol Chem, vol.280, pp.27924-27934, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00016899

T. Bartsch, Focal lesions of human hippocampal CA1 neurons in transient global amnesia impair place memory, Science, vol.328, pp.1412-1415, 2010.

M. J. Benjamin, A. Cifelli, P. Garrard, and D. Caine, Jones FW The role of working memory and verbal fluency in autobiographical memory in early Alzheimer's disease and matched controls, Neuropsychologia, vol.78, pp.115-121, 2015.

F. Bianchini, A selective egocentric topographical working memory deficit in the early stages of Alzheimer's disease: a preliminary study, Am J Alzheimers Dis Other Demen, vol.29, pp.749-754, 2014.

Y. Bouter, N-truncated amyloid beta (Abeta) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits, Acta Neuropathol, vol.126, pp.189-205, 2013.

N. J. Broadbent, L. R. Squire, and R. E. Clark, Reversible hippocampal lesions disrupt water maze performance during both recent and remote memory tests, Learn Mem, vol.13, pp.187-191, 2006.

M. W. Brown, G. R. Barker, J. P. Aggleton, and E. C. Warburton, What pharmacological interventions indicate concerning the role of the perirhinal cortex in recognition memory, Neuropsychologia, vol.50, pp.3122-3140, 2012.

N. Callizot, M. Combes, R. Steinschneider, and P. Poindron, Operational dissection of beta-amyloid cytopathic effects on cultured neurons, J Neurosci Res, vol.91, pp.706-716, 2013.

A. Cavalli, Multi-target-directed ligands to combat neurodegenerative diseases, J Med Chem, vol.51, pp.347-372, 2008.

S. Cho and Y. Hu, Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival, Exp Neurol, vol.203, pp.274-278, 2007.

M. Citron, Alzheimer's disease: strategies for disease modification, Nat Rev Drug Discov, 2010.

M. J. Curtis, S. Alexander, G. Cirino, J. R. Docherty, C. H. George et al., , 2018.

, Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers, Br J Pharmacol, vol.175, pp.987-993

N. Crouzin, Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of
URL : https://hal.archives-ouvertes.fr/hal-00868441

, Alzheimer's disease: dissociation between somatosensory cortex and hippocampus, PLoS One, vol.8, p.74667, 2013.

L. Morrell, MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD, Neurobiol Aging, vol.25, pp.1197-1203, 2004.

C. Desbene, Critical role of cPLA2 in Abeta oligomer-induced neurodegeneration and memory deficit, Neurobiol Aging, vol.33, pp.1123-1117, 2012.

T. Freret, J. M. Billard, P. Schumann-bard, P. Dutar, F. Dauphin et al., , 2012.

, Rescue of cognitive aging by long-lasting environmental enrichment exposure initiated before median lifespan, Neurobiol Aging, vol.33, pp.1005-1001

T. Freret, V. Lelong-boulouard, P. Lecouflet, K. Hamidouche, F. Dauphin et al., Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse, Psychopharmacology (Berl), vol.234, pp.2365-2374, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02135214

L. Frolich, Open-label, multicenter, phase III extension study of idalopirdine as adjunctive to donepezil for the treatment of mild-moderate Alzheimer's disease, J Alzheimers Dis, vol.67, pp.303-313, 2019.

P. Garcia, Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease, J Neurosci, vol.30, p.7516, 2010.

P. Giannoni, Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease, Front Aging Neurosci, vol.5, p.96, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01703910

P. Giannoni, Cerebrovascular pathology during the progression of experimental
URL : https://hal.archives-ouvertes.fr/hal-01477817

, Alzheimer's disease, Neurobiol Dis, vol.88, pp.107-117, 2016.

S. D. Girard, Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease, Hippocampus, vol.24, pp.762-772, 2014.

N. J. Goodrich-hunsaker, S. A. Livingstone, R. W. Skelton, and R. O. Hopkins, Spatial deficits in a virtual water maze in amnesic participants with hippocampal damage, Hippocampus, vol.20, p.481, 2010.

S. D. Harding, J. L. Sharman, E. Faccenda, C. Southan, A. J. Pawson et al., The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY, Nucl Acids Res, vol.46, pp.1091-1106, 2018.

N. C. Inestrosa, Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into

, Alzheimer's fibrils: possible role of the peripheral site of the enzyme, Neuron, vol.16, pp.881-891, 1996.

A. Jan, D. M. Hartley, and H. A. Lashuel, Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research, Nat Protoc, vol.5, pp.1186-1209, 2010.

H. Kilbinger and D. Wolf, Effects of 5-HT4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus, Naunyn-Schmiedeberg's Arch Pharmacol, vol.345, pp.270-275, 1992.

B. Kriem, Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide, FASEB J, vol.19, pp.85-87, 2005.

D. Lagun, C. Manzanares, S. M. Zola, E. A. Buffalo, and E. Agichtein, Detecting cognitive impairment by eye movement analysis using automatic classification algorithms, J Neurosci Methods, vol.201, pp.196-203, 2011.

C. Lecoutey, Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

, Proc Natl Acad Sci, vol.111, pp.3825-3830, 2014.

M. Leger, A. Quiedeville, V. Bouet, B. Haelewyn, M. Boulouard et al., , 2013.

, Object recognition test in mice, Nat Protoc, vol.8, pp.2531-2537

M. Maillet, Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha, Nat Cell Biol, vol.5, pp.633-639, 2003.

C. Malaplate-armand, Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway, Neurobiol Dis, vol.23, pp.178-189, 2006.

S. J. Martin, L. De-hoz, and R. G. Morris, Retrograde amnesia: neither partial nor complete hippocampal lesions in rats result in preferential sparing of remote spatial memory, even after reminding, Neuropsychologia, vol.43, pp.609-624, 2005.

I. Melnikova, Therapies for Alzheimer's disease, Nat Rev Drug Discov, vol.6, pp.341-342, 2007.

M. Rosini, E. Simoni, A. Minarini, and C. Melchiorre, Multi-target design strategies in the context of

, Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces, Neurochem Res, vol.39, pp.1914-1923, 2014.

A. Musial, M. Bajda, and B. Malawska, Recent developments in cholinesterases inhibitors for

, Alzheimer's disease treatment, Curr Med Chem, vol.14, pp.2654-2679, 2007.

D. G. Mumby, R. S. Astur, M. P. Weisend, and R. J. Sutherland, Retrograde amnesia and selective damage to the hippocampal formation: memory for places and object discriminations, Behav Brain Res, vol.106, issue.1-2, pp.97-107, 1999.

G. Norman and M. J. Eacott, Dissociable effects of lesions to the perirhinal cortex and the postrhinal cortex on memory for context and objects in rats, Behav Neurosci, vol.119, pp.557-566, 2005.

H. Oakley, Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation, J Neurosci, vol.26, pp.10129-10140, 2006.

T. Pillot, The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain, J Neurochem, vol.73, pp.1626-1634, 1999.

C. Rochais, Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride, J Med Chem, vol.58, pp.3172-3187, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02043873

M. Sakono and T. Zako, Amyloid oligomers: formation and toxicity of Abeta oligomers, FEBS J, vol.277, pp.1348-1358, 2010.

M. Sarter, H. H. Schneider, and D. N. Stephens, Treatment strategies for senile dementia: antagonist beta-carbolines, Trends Neurosci, vol.11, pp.13-17, 1988.

B. Schmitt, T. Bernhardt, H. J. Moeller, I. Heuser, and L. Frolich, Combination therapy in Alzheimer's disease: a review of current evidence, CNS Drugs, vol.18, pp.827-844, 2004.

M. L. Schroeter, Executive deficits are related to the inferior frontal junction in early dementia, Brain, vol.135, pp.201-215, 2012.

T. Spellman, Hippocampal-prefrontal input supports spatial encoding in working memory, Nature, vol.522, pp.309-314, 2015.

T. R. Stoub, MRI predictors of risk of incident Alzheimer disease: a longitudinal study, Neurology, vol.64, pp.1520-1524, 2005.

K. I. Taylor, A. Probst, A. R. Miserez, A. U. Monsch, and M. Tolnay, Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease, Nat Clin Pract Neurol, 2008.

R. Vidal, E. M. Valdizan, R. Mostany, A. Pazos, and E. Castro, Long-term treatment with fluoxetine induces desensitization of 5-HT4 receptor-dependent signalling and functionality in rat brain, J Neurochem, vol.110, pp.1120-1127, 2009.

T. L. Wallace, T. M. Ballard, and C. Glavis-bloom, Animal paradigms to assess cognition with translation to humans, Handb Exp Pharmacol, vol.228, pp.27-57, 2015.

H. C. Watson and A. C. Lee, The perirhinal cortex and recognition memory interference, J Neurosci, vol.33, pp.4192-4200, 2013.

H. Wang and H. Zhang, Reconsideration of anticholinesterase therapeutic strategies against Alzheimer's disease, ACS Chem Neurosci, vol.10, issue.2, pp.852-862, 2019.

T. Yoon, J. Okada, M. W. Jung, and J. J. Kim, Prefrontal cortex and hippocampus subserve different components of working memory in rats, Learn Mem, vol.15, pp.97-105, 2008.

I. Youssef, N-truncated amyloid-beta oligomers induce learning impairment and neuronal apoptosis, Neurobiol Aging, vol.29, pp.1319-1333, 2008.

A. Zeamer, R. L. Richardson, A. R. Weiss, and J. Bachevalier, The development of object recognition memory in rhesus macaques with neonatal lesions of the perirhinal cortex, Dev Cogn Neurosci, vol.11, pp.31-41, 2015.

S. M. Zola, C. M. Manzanares, P. Clopton, J. J. Lah, and A. I. Levey, A behavioral task predicts conversion to mild cognitive impairment and Alzheimer's disease, Am J Alzheimers Dis Other Demen, vol.28, pp.179-184, 2013.

, After permeabilization with 0.1% of saponin, cells will be incubated for 2 hours with 1/ a chicken polyclonal antibody anti microtubule-associated-protein 2 (MAP-2, RRID:AB_2138153), diluted at 1/1000 in PBS containing 1% fetal calf serum and 0.1% of saponin (this antibody allows the specific staining of neuronal cell bodies and neurites; and allow the study of neuronal cell death and neurite network) or 2/ a mouse monoclonal antibody anti-phospho Tau (AT100, RRID:AB_223652) at dilution of 1/400 in PBS containing 1% fetal calf serum and 0.1% of saponin, hours after intoxication, the hippocampal neurons were fixed by a cold solution of ethanol (95%) and acetic acid (5%) for 5 min at -20°C

, Synapses evaluation 24 hours after intoxication, the hippocampal neurons were fixed by a cold solution of ethanol (95%) and acetic acid (5%) for 5 min at -20°C. After permeabilization with 0.1% of saponin, cells were incubated for 2 hours with: 1/ a mouse monoclonal antibody anti post synaptic density 95kDa (PSD95, RRID:AB_300453) at a dilution of 1/100 in PBS containing 1% fetal calf serum and 0.1% of saponin or 2/ a rabbit polyclonal antibody anti-synaptophysin (SYN, RRID:AB_306124) at the dilution of 1/100 in PBS containing 1% fetal calf serum and 0.1% of saponin. These antibodies were revealed with Alexa Fluor 488 goat anti mouse IgG and Alexa Fluor 568 goat anti-rabbit IgG at the dilution 1/400 in PBS containing 1% FCS, 0.1% saponin, the dilution 1/400 in PBS containing 1% FCS, 0.1% saponin, for 1 hour at room temperature

, Synapses evaluation were performed automatically by using Custom module editor (Molecular Devices). The total number of synapses (overlapping between PSD95/SYN) was then assessed

H. Oakley, Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation, J Neurosci, vol.26, issue.40, pp.10129-10140, 2006.

K. Baranger, MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease, Cell Mol Life Sci, vol.73, issue.1, pp.217-236, 2016.

C. Lecoutey, Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment, Proc Natl Acad Sci U S A, vol.111, issue.36, pp.3825-3830, 2014.

M. Morishima-kawashima, Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain, Am J Pathol, vol.157, issue.6, pp.2093-2099, 2000.

R. A. Bevins and J. Besheer, Object recognition in rats and mice: a one-trial non-matching-tosample learning task to study 'recognition memory', Nat Protoc, vol.1, issue.3, pp.1306-1311, 2006.

P. Garcia, Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease, J Neurosci, vol.30, issue.22, pp.7516-7527, 2010.

N. Callizot, M. Combes, R. Steinschneider, and P. Poindron, Operational dissection of beta-amyloid cytopathic effects on cultured neurons, J Neurosci Res, vol.91, issue.5, pp.706-716, 2013.